Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer.Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
